Other – Europabio

30/11/2022

30/11/2022

EuropaBio presents EFIB Vilnius Statement to European policymakers

25/11/2022

25/11/2022

The time to act is now! Biotechnology for global transformation

16/11/2022

16/11/2022

Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides

30/09/2022

30/09/2022

Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe

19/09/2022

19/09/2022

Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.

27/07/2022

27/07/2022

EuropaBio position on the European Health Data Space proposal

18/07/2022

18/07/2022

EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)

13/07/2022

13/07/2022

Recombinant DNA in fermentation products is of no regulatory relevance

24/06/2022

24/06/2022

Considering microorganisms and New Genomic Techniques: on the need for a new GMO legislation in the European Union

25/05/2022

25/05/2022

European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi

23/05/2022

23/05/2022

Big Changes Start Small

25/04/2022

25/04/2022

Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

16/03/2022

16/03/2022

EuropaBio response to the Call for Evidence on Soil health – protecting, sustainably managing and restoring EU soils

28/02/2022

28/02/2022

EuropaBio Statement on Rare Disease Day

01/12/2021

01/12/2021

EUBA position on the JRC LCA Methodology

22/11/2021

22/11/2021

The review of the general pharmaceutical legislation: an opportunity that should not be missed?

08/11/2021

08/11/2021

What is the use of innovation if it cannot be implemented? Or why consumers have the last word

27/10/2021

27/10/2021

EuropaBio Comments on the Roadmap on a Policy Framework on Biobased, Biodegradable and Compostable Plastics

26/10/2021

26/10/2021

EuropaBio response to the public consultation on the roadmap on Sustainable Food Systems

22/10/2021

22/10/2021

EuropaBio Response to the Inception Impact Assessment for Legislation for Plants Produced from Certain New Genomic Techniques (NGTs)

04/10/2021

04/10/2021

EuropaBio Comments on the Roadmap on Restoring Sustainable Carbon Cycles

30/09/2021

30/09/2021

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?

27/08/2021

27/08/2021

EuropaBio response to the Public consultation on European bioeconomy policy: stocktaking and future developments

EuropaBio comments on the public consultation on blue bioeconomy.